K

Kalaris Therapeutics, Inc. (KLRS)

NGM – Real Time Price. Currency in USD

4.06

+0.09 (2.27%)

Market open: Aug 12, 2026, 10:19 AM EDT

4.04

+0.07 (1.76%)

Previous after-hours: Aug 11, 2026, 7:40 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Kalaris Therapeutics, Inc. (KLRS)

NGM – Real Time Price. Currency in USD

4.06

+0.09 (2.27%)

Market open: Aug 12, 2026, 10:19 AM EDT

4.04

+0.07 (1.76%)

Previous after-hours: Aug 11, 2026, 7:40 PM EDT

04.08.2026

KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders

Abbott Cooper PLLC is investigating fiduciary duty claims for Kalaris Therapeutics (formerly AlloVir) holders who owned shares before November 7, 2024.

Videos

No Data

There is no data to display

Press releases

04.08.2026

KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders

Abbott Cooper PLLC is investigating fiduciary duty claims for Kalaris Therapeutics (formerly AlloVir) holders who owned shares before November 7, 2024.

Search stocks

Kalaris Therapeutics, Inc. (KLRS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Kalaris Therapeutics, Inc. (KLRS)

KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders

Videos

No Data

Press releases

KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders